Douglas Hägerström

1.8k total citations
13 papers, 908 citations indexed

About

Douglas Hägerström is a scholar working on Physiology, Psychiatry and Mental health and Neurology. According to data from OpenAlex, Douglas Hägerström has authored 13 papers receiving a total of 908 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 7 papers in Psychiatry and Mental health and 5 papers in Neurology. Recurrent topics in Douglas Hägerström's work include Alzheimer's disease research and treatments (8 papers), Dementia and Cognitive Impairment Research (7 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Douglas Hägerström is often cited by papers focused on Alzheimer's disease research and treatments (8 papers), Dementia and Cognitive Impairment Research (7 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Douglas Hägerström collaborates with scholars based in Sweden, United States and Switzerland. Douglas Hägerström's co-authors include Oskar Hansson, Ruben Smith, Jonas Jögi, Kaj Blennow, Henrik Zetterberg, Michael Schöll, Sebastian Palmqvist, Tomas Ohlsson, Olof Strandberg and Lennart Minthon and has published in prestigious journals such as Neurology, Movement Disorders and Journal of Nuclear Medicine.

In The Last Decade

Douglas Hägerström

13 papers receiving 904 citations

Peers

Countries citing papers authored by Douglas Hägerström

Since Specialization

Citations

This map shows the geographic impact of Douglas Hägerström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Hägerström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Hägerström more than expected).

Fields of papers citing papers by Douglas Hägerström

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Hägerström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Hägerström. The network helps show where Douglas Hägerström may publish in the future.

Co-authorship network of co-authors of Douglas Hägerström

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Hägerström. A scholar is included among the top collaborators of Douglas Hägerström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Hägerström. Douglas Hägerström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Clinical Utility of Tau Positron Emission Tomography in the Diagnostic Workup of Patients With Cognitive Symptoms 2023 ·JAMA Neurology ·Ruben Smith, Douglas Hägerström, (unknown), Gregory Klein, Jonas Jögi, Tomas Ohlsson, Erik Stomrud, Oskar Hansson	18
2	Comparing ¹⁸ F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease 2018 ·Neurology ·Niklas Mattsson, Ruben Smith, Olof Strandberg, Sebastian Palmqvist, Michael Schöll, Philip S. Insel, Douglas Hägerström, Tomas Ohlsson, Henrik Zetterberg, Kaj Blennow, Jonas Jögi, Oskar Hansson	69
3	¹⁸ F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease 2017 ·EMBO Molecular Medicine ·Niklas Mattsson, Michael Schöll, Olof Strandberg, Ruben Smith, Sebastian Palmqvist, Philip S. Insel, Douglas Hägerström, Tomas Ohlsson, Henrik Zetterberg, Jonas Jögi, Kaj Blennow, Oskar Hansson	131
4	Tau Pathology Distribution in Alzheimer's disease Corresponds Differentially to Cognition-Relevant Functional Brain Networks 2017 ·Frontiers in Neuroscience ·Oskar Hansson, Michel J. Grothe, Tor Olof Strandberg, Tomas Ohlsson, Douglas Hägerström, Jonas Jögi, Ruben Smith, Michael Schöll	73
5	In vivo retention of ¹⁸ F-AV-1451 in corticobasal syndrome 2017 ·Neurology ·Ruben Smith, Michael Schöll, Håkan Widner, Danielle van Westen, Per Svenningsson, Douglas Hägerström, Tomas Ohlsson, Jonas Jögi, Christer Nilsson, Oskar Hansson	81
6	Modeling Strategies for Quantification of In Vivo ¹⁸F-AV-1451 Binding in Patients with Tau Pathology 2016 ·Journal of Nuclear Medicine ·Andreas Hahn, Martin Schain, Maria Erlandsson, (unknown), Gregory M. James, Olof Strandberg, Douglas Hägerström, Rupert Lanzenberger, Jonas Jögi, (unknown), Ruben Smith, Oskar Hansson	47
7	Posterior Accumulation of Tau and Concordant Hypometabolism in an Early-Onset Alzheimer’s Disease Patient with Presenilin-1 Mutation 2016 ·Journal of Alzheimer s Disease ·Ruben Smith, Moa Wibom, (unknown), Douglas Hägerström, Jonas Jögi, Gil D. Rabinovici, Oskar Hansson	24
8	Increased basal ganglia binding of ¹⁸F‐AV‐1451 in patients with progressive supranuclear palsy 2016 ·Movement Disorders ·Ruben Smith, Martin Schain, Christer Nilsson, Olof Strandberg, Tomas Olsson, Douglas Hägerström, Jonas Jögi, Edilio Borroni, Michael Schöll, Michael Honer, Oskar Hansson	94
9	P3‐224: Age‐Related Increase in Basal Ganglia Binding of ¹⁸F‐AV1451 in Healthy Elderly and Patients with Progressive Supranuclear Palsy 2016 ·Alzheimer s & Dementia ·Ruben Smith, Martin Schain, Christer Nilsson, Tomas Olsson, Douglas Hägerström, Jonas Jögi, Edilio Borroni, Michael Honer, Oskar Hansson	1
10	Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42 2014 ·JAMA Neurology ·Sebastian Palmqvist, Henrik Zetterberg, Kaj Blennow, Susanna Vestberg, Ulf Andréasson, David J. Brooks, Rikard Owenius, Douglas Hägerström, Per Wollmer, Lennart Minthon, Oskar Hansson	275
11	CSF Biomarkers Correlate with Cerebral Blood Flow on SPECT in Healthy Elderly 2012 ·Dementia and Geriatric Cognitive Disorders ·Erik Stomrud, Anton Forsberg, Douglas Hägerström, Erik Ryding, Kaj Blennow, Henrik Zetterberg, Lennart Minthon, Oskar Hansson, Elisabet Londos	15
12	A new automated method for analysis of rCBF‐SPECT images based on the active‐shape algorithm: normal values 2011 ·Clinical Physiology and Functional Imaging ·Douglas Hägerström, (unknown), Erik Stomrud, (unknown), Erik Ryding, Elisabet Londos, Lennart Minthon, Ingmar Rosén, Lars Edenbrandt	3
13	A Swedish family with de novo α-synuclein A53T mutation: Evidence for early cortical dysfunction 2009 ·Parkinsonism & Related Disorders ·Andreas Puschmann, Owen A. Ross, Carles Vilariño‐Güell, Sarah Lincoln, Jennifer M. Kachergus, Stephanie A. Cobb, Suzanne Granhøj Lindquist, Jørgen E. Nielsen, Zbigniew K. Wszołek, Matthew J. Farrer, Håkan Widner, Danielle van Westen, Douglas Hägerström, Katerina Markopoulou, Bruce A. Chase, Karin Nilsson, Jan Reimer, Christer Nilsson	77

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact